Desmoid Neoplasm

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2022-03-25
Clinical Trial Update: Doxorubicin Eluting Intra-arterial Embolization for Aggressive Desmoid Fibromatosis [Phase 2]
Phase 2 trial evaluating doxorubicin-eluting intra-arterial embolization for aggressive desmoid fibromatosis has completed.